Daiwa Securities Group
ARCT icon

Daiwa Securities Group’s Arcturus Therapeutics ARCT Stock Holding History

Daiwa Securities Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-90
Closed -$1K – 1204
2025
Q4 		$1K Hold
90
– – ﹤0.01% 1337
2025
Q3 		$2K Hold
90
– – ﹤0.01% 1258
2025
Q2 		$1K Hold
90
– – ﹤0.01% 1246
2025
Q1 		$1K Hold
90
– – ﹤0.01% 1212
2024
Q4 		$2K Hold
90
– – ﹤0.01% 1210
2024
Q3 		$2K Hold
90
– – ﹤0.01% 1212
2024
Q2 		$2K Hold
90
– – ﹤0.01% 1242
2024
Q1 		$3K Hold
90
– – ﹤0.01% 1231
2023
Q4 		$3K Hold
90
– – ﹤0.01% 1238
2023
Q3 		$2K Hold
90
– – ﹤0.01% 1211
2023
Q2 		$3K Sell
90
-4,019
-98% -$109K ﹤0.01% 1212
2023
Q1 		$98K Buy
4,109
+789
+24% +$14.2K ﹤0.01% 995
2022
Q4 		$56K Sell
3,320
-1,540
-32% -$26.9K ﹤0.01% 1023
2022
Q3 		$72K Sell
4,860
-1,044
-18% -$17.5K ﹤0.01% 1031
2022
Q2 		$93K Buy
5,904
+2,401
+69% +$47.1K ﹤0.01% 1031
2022
Q1 		$94K Buy
3,503
+1,071
+44% +$27.3K ﹤0.01% 1048
2021
Q4 		$90K Buy
2,432
+322
+15% +$13.1K ﹤0.01% 1022
2021
Q3 		$101K Buy
2,110
+2,064
+4,487% +$92.5K ﹤0.01% 993
2021
Q2 		$2K Hold
46
– – ﹤0.01% 1134
2021
Q1 		$2K Hold
46
– – ﹤0.01% 1135
2020
Q4 		$2K Buy
+46
New +$3.12K ﹤0.01% 1111

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Daiwa Securities Group's ARCT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 90 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in ARCT in Q4 2020 and held it in 21 quarters. The position peaked at $101K in Q3 2021. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Daiwa Securities Group reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 90 Arcturus Therapeutics shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 21 quarters.
  • Daiwa Securities Group's Arcturus Therapeutics position peaked at $101K in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.